Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Wait-list Controlled Trial on the Use of Emotional Freedom Techniques as an Intervention Strategy to Reduce Patient Reported Cognitive Complaints in Cancer Survivors on Behalf of the Belgian Society for Medical Oncology (BSMO)-Cancer Survivorship Taskforce

NCT02771028 is registered in ClinicalTrials.gov with General Hospital Groeninge as lead sponsor.

NCT NCT02771028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02771028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Wait-list Controlled Trial on the Use of Emotional Freedom Techniques as an Intervention Strategy to Reduce Patient Reported Cognitive Complaints in Cancer Survivors on Behalf of the Belgian Society for Medical Oncology (BSMO)-Cancer Survivorship Taskforce
Lead sponsor
General Hospital Groeninge
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2016
Completion date
March 15, 2021
Enrollment
121 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, subjective cognitive complaints